OlamkiceptDrug candidate: IL-6 trans-signalling inhibitor (licensed to Ferring Pharmaceuticals)
CR12/01Drug candidate: Modulator of intestinal microbiota (small molecule)
CR12/02Drug candidate: Modulator of intestinal microbiota (small molecule)
CR13/01Drug candidate: Transfer of sterile fecal microbiota filtrates (sold in 2017)
CR19/01-04Food supplement: Combination of intestinal microbiota modulators (out-licensed in 2020)

16 February, 2022